How Managed Entry Agreements Influence the Patients’ Affordability to Biological Medicines—Bulgarian Example

Managed entry agreements are applied in almost all European countries in order to improve patients’ access to therapy. The current study aims to evaluate the changes in the affordability of biological medicines for patients in Bulgaria during 2019–2022. The study is a top-down macroeconomic analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitkova, Zornitsa, Manev, Ivan, Tachkov, Konstantin, Boyadzhieva, Vladimira, Stoilov, Nikolay, Doneva, Miglena, Petrova, Guenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486911/
https://www.ncbi.nlm.nih.gov/pubmed/37685461
http://dx.doi.org/10.3390/healthcare11172427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486911/
https://www.ncbi.nlm.nih.gov/pubmed/37685461
http://dx.doi.org/10.3390/healthcare11172427

Ejemplares similares